Fundraising FoxImmuneXcite
Waltham, US · Founded 2007 · Delaware corporation
Find your way into ImmuneXcite
Sign up to see every warm intro you have to ImmuneXcite
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmuneXcite team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EF
Eric FurfineExecutive
JE
John EdwardsExecutive
YB
Yaniv BejeranoExecutive
Board
DS
David SchechterBoard director
AD
Ann DeWittBoard director
ER
Eric RowinskyBoard director
JG
James GeraghtyBoard director
SJ
Stonberg JeffBoard director
Reported raises · per SEC filings
Form D private placements$17.6M disclosed across 4 rounds · 2011–2017
▶$8.9MraisedFeb 2017 · 81 investors · BiotechnologyRule 506(b)
▶$8.9MraisedFeb 2017 · 81 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric FurfineExecutive Officer, Director
- Ann DeWittDirector
- David SchechterDirector
- Eric RowinskyDirector
- James GeraghtyDirector
- John EdwardsExecutive Officer, Director
- Offering amount
- $10.9M
- Amount sold
- $8.9M
- Proceeds to insiders
- $360K
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedFeb 2017 · 47 investors · BiotechnologyRule 506(b)
▶$2.7MraisedFeb 2017 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchechterDirector
- Eric FurfineExecutive Officer, Director
- John EdwardsExecutive Officer, Director
- Ann DeWittDirector
- Eric RowinskyDirector
- James GeraghtyDirector
- Offering amount
- $3M
- Amount sold
- $2.7M
- Minimum investment
- $512
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedJan 2014 · 51 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJan 2014 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric RowinskyDirector
- Valerie FriedmanDirector
- Yaniv BejeranoExecutive Officer, Director
- David SchechterDirector
- Offering amount
- $4.1M
- Amount sold
- $3.6M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedJan 2012 · 36 investors · BiotechnologyRule 506(b)
▶$2.4MraisedJan 2012 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yaniv BejeranoExecutive Officer, Director
- Stonberg JeffDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ImmuneXcite raised?
- ImmuneXcite has disclosed $17.6M raised across 4 rounds.
- Where is ImmuneXcite headquartered?
- ImmuneXcite is headquartered in Waltham, US.